Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02255591
Other study ID # AUH-TFB-SR
Secondary ID 2013-005346-10
Status Completed
Phase Phase 4
First received September 22, 2014
Last updated April 30, 2015
Start date February 2015
Est. completion date March 2015

Study information

Verified date September 2014
Source University of Aarhus
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Health and Medicines AuthorityDenmark: The National Committee on Health Research Ethics
Study type Interventional

Clinical Trial Summary

The main objective of the trial is to complete a double-blinded randomized controlled trial of a lumbar plexus block with the Shamrock technique versus the Lumbar Ultrasound Trident technique by estimating the time of performance of lumbar plexus blocks in healthy volunteers.

Secondary objectives include a) estimates of number and depth of needle injections, distance of injection site from the midline, minimal electric nerve stimulation to trigger muscular response and the type of response, and volunteer discomfort during block injection, b) measurements of plasma lidocaine and mean arterial blood pressure, c) examinations of sensory block of the dermatomes T8-S3 and motor block of the femoral nerve, the obturator nerve, the hip abductor muscles, and the hamstring muscles, d) success rate of lumbar plexus block, e) perineural and epidural distribution of local anesthetics added contrast visualized on magnetic resonance imaging (MRI) scanning, and f) cost-effectiveness for the Shamrock technique versus the Lumbar Ultrasound Trident Technique for lumbar plexus block in healthy volunteers.

The hypothesis is that the Shamrock technique is faster to perform than the Lumbar Ultrasound technique, and that the success rate of the Shamrock technique is equal to or higher than the Lumbar Ultrasound Trident technique.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 2015
Est. primary completion date March 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Male

- Age = 18 years

- Volunteers who have given their written and oral consent to participate in the study after fully understanding the content and the limitations of the protocol

- Normal healthy volunteer (American Society of Anesthesiology (ASA) Classification I)

Exclusion Criteria:

- Volunteers not able to cooperate for the study

- Volunteers not able to understand Danish

- Daily use of analgesics

- Allergy against the medicines used in the study

- Drug abuse (according to the investigator's judgement)

- Alcohol consumption larger than the recommendations of the Danish National Board of Health

- Volunteers in whom nerve blocks are not possible due to technical reasons

- Volunteers who meet any contraindication for MRI including claustrophobia

- Volunteers who are incompetent, i.e. surrogate consent is not accepted

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Lidocaine-adrenaline added gadolinium.


Locations

Country Name City State
Denmark Department of Aneshtesiology and Intensive Care Medicine; Aarhus University Hospital Aarhus C

Sponsors (2)

Lead Sponsor Collaborator
University of Aarhus AP Moeller Foundation

Country where clinical trial is conducted

Denmark, 

References & Publications (7)

de Visme V, Picart F, Le Jouan R, Legrand A, Savry C, Morin V. Combined lumbar and sacral plexus block compared with plain bupivacaine spinal anesthesia for hip fractures in the elderly. Reg Anesth Pain Med. 2000 Mar-Apr;25(2):158-62. — View Citation

Doi K, Sakura S, Hara K. A modified posterior approach to lumbar plexus block using a transverse ultrasound image and an approach from the lateral border of the transducer. Anaesth Intensive Care. 2010 Jan;38(1):213-4. — View Citation

Karmakar MK, Ho AM, Li X, Kwok WH, Tsang K, Ngan Kee WD. Ultrasound-guided lumbar plexus block through the acoustic window of the lumbar ultrasound trident. Br J Anaesth. 2008 Apr;100(4):533-7. doi: 10.1093/bja/aen026. — View Citation

Kirchmair L, Entner T, Kapral S, Mitterschiffthaler G. Ultrasound guidance for the psoas compartment block: an imaging study. Anesth Analg. 2002 Mar;94(3):706-10; table of contents. — View Citation

Kirchmair L, Entner T, Wissel J, Moriggl B, Kapral S, Mitterschiffthaler G. A study of the paravertebral anatomy for ultrasound-guided posterior lumbar plexus block. Anesth Analg. 2001 Aug;93(2):477-81, 4th contents page. — View Citation

Madison SJ, Ilfeld BM, Loland VJ, Mariano ER. Posterior lumbar plexus perineural catheter insertion by ultrasound guidance alone. Acta Anaesthesiol Scand. 2011 Sep;55(8):1031-2. doi: 10.1111/j.1399-6576.2011.02489.x. Epub 2011 Jul 20. — View Citation

Morimoto M, Kim JT, Popovic J, Jain S, Bekker A. Ultrasound-guided lumbar plexus block for open reduction and internal fixation of hip fracture. Pain Pract. 2006 Jun;6(2):124-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Block performance time Time for performance of lumbar plexus block in seconds from placement of the ultrasound transducer on the skin until the block needle is pulled out after injection of local anesthetics. Estimated 0 minutes after block placement. Presented 10 months after the last visit of the last volunteer. No
Secondary Number of needle feeds Needle feeds are defined as retraction of needle followed by new feed of the needle disregarding the number of skin punctures. Estimated 0 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Discomfort during block placement Discomfort is measured with Numeric Rating Scale (NRS). Estimated 1 minute after block placement. Presented 10 months after the last visit of the last volunteer. No
Secondary Plasma Lidocaine Blood samples are withdrawn 0, 5, 10, 20, 40, 60, and 90 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Mear arterial pressure Measured 5 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Cost-effectiveness Cost-effectiveness estimated as extra expense per successful lumbar plexus block and calculated as incremental cost-effectiveness ratio (ICER). Calculated two weeks after the last visit of the last volunteer. Presented 10 months after the last visit of the last volunteer. No
Secondary Sensor block Sensor block (cold, warm, touch, and pain) of the dermatomes T8-S3 and of the femoral nerve and the lateral femoral cutaneous nerve. Tested 30 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Motor block Motor block of the femoral nerve (knee extension), the obturator nerve (hip adduction), the superior gluteal nerve (hip abduction), and the sciatic nerve (knee flexion) estimated as active resistance against movement of the relevant joint and with sphygmomanometer of the relevant joint as maximal voluntary isometric contraction with dynamometer (mmHg). Tested 40 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Block success rate Success rate defined as motor block of the femoral nerve (knee extension) and the obturator nerve (hip adduction) and reduced sensory of the lateral femoral cutaneous nerve (middle of the lateral side of the thigh). Tested 30 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Block success rate Defined as above after lumbar plexus block with the Shamrock technique for motor response on electrical nerve stimulation above respectively below 0,5 milliampere (mA). Tested 30 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Epidural spread of local anesthetics with contrast Estimated with T1- and T2-weighted and with diffusion weighted imaging (DWI) MR scanning. Estimated 10-30 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Perineural spread of local anesthetics with added contrast Estimated with T1- and T2-weighted and with DWI MR scanning. Estimated 10-30 minutes after block placement. Presented 10 months after the last visit of the last volunteer. Yes
Secondary Depth of block needle The depth in cm from the injection site in the skin to the needle tips position during injection. of local anesthetics Estimated during block Yes
Secondary Injection site The distance in cm from the injection site of the block needle to the midline of the volunteer. Estimated immediately after block placement Yes
Secondary Minimal electrical nerve stimulation The estimated minimal electrical nerve stimulation in mA to trigger a muscular response. Estimated immediately before injection of local anesthetics during block placement Yes
Secondary Type of response on electrical nerve stimulation The type of response triggered by electrical nerve stimulation. Assessed immediately before injection of local anesthetics during block placement Yes
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2